Status:
UNKNOWN
COVID-19 Infection and Fetal-neonatal Outcomes
Lead Sponsor:
University of Campania Luigi Vanvitelli
Conditions:
Covid19
Obstetric Complication
Eligibility:
FEMALE
18+ years
Brief Summary
COVID-19, the coronavirus responsible for the pandemic that began at the end of 2019 in China, spreads through respiratory droplets and direct contact. The most common symptoms of the disease include ...
Detailed Description
Coronaviruses are a large family of viruses known to cause illnesses ranging from the common cold to more serious illnesses such as Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory...
Eligibility Criteria
Inclusion
- Maternal age\> 18 years
- Women with single or multiple pregnancy at any stage of gestation, with first ascertained positivity to the nasopharyngeal swab for SARS-CoV-2 during pregnancy, regardless of the presence of symptoms.
Exclusion
- age under 18.
- Women with an altered state of consciousness, seriously ill, with mental handicaps;
- Women with serious systemic diseases that can negatively affect the pregnancy outcome.
- Women for whom the treating doctor contraindicates participation in the study.
Key Trial Info
Start Date :
December 28 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2022
Estimated Enrollment :
230 Patients enrolled
Trial Details
Trial ID
NCT04699578
Start Date
December 28 2020
End Date
May 1 2022
Last Update
January 7 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Campania Luigi Vanvitelli
Naples, Italy, 80138